0.
156. Takagi H, Umemoto T. A meta-analysis of circulating
homocysteine levels in subjects with versus without
abdominal aortic aneurysm. Int Angiol 2015;34:229-37.
157. Cao H, Hu X, Zhang Q, Li J, Wang J, Shao Y, et al. Homocysteine level and risk of abdominal aortic aneurysm: a
meta-analysis. PLoS One 2014;9:e85831.
158. Golledge J, Tsao PS, Dalman RL, Norman PE. Circulating
markers of abdominal aortic aneurysm presence and progression. Circulation 2008;118:2382-92.
159. Sidloff DA, Stather PW, Choke E, Bown MJ, Sayers RD.
A systematic review and meta-analysis of the association
between markers of hemostasis and abdominal aortic
aneurysm presence and size. J Vasc Surg 2014;59:528-35.e4.
160. Stather PW, Sidloff DA, Dattani N, Gokani VJ, Choke E,
Sayers RD, et al. Meta-analysis and meta-regression analysis
of biomarkers for abdominal aortic aneurysm. Br J Surg
2014;101:1358-72.
161. Norman P, Spencer CA, Lawrence-Brown MM, Jamrozik K.
C-reactive protein levels and the expansion of screendetected abdominal aortic aneurysms in men. Circulation
2004;110:862-6.
162. Maegdefessel L, Azuma J, Toh R, Merk DR, Deng A, Chin JT,
et al. Inhibition of microRNA-29b reduces murine abdominal aortic aneurysm development. J Clin Invest 2012;122:
497-506.
163. Maegdefessel L, Dalman RL, Tsao PS. Pathogenesis of
abdominal aortic aneurysms: micro